“Increase in R&D Spending on Biopharmaceutical Projects”
The increase in R&D spending on biopharmaceutical projects is driving the growth of the global cell culture media market. Biopharmaceutical companies are investing heavily in R&D to develop new treatments and therapies, which requires the use of high-quality cell culture media to support the growth and testing of biological products. As a result, the demand for cell culture media is increasing as biopharmaceutical companies require advanced cell culture media to support their R&D activities. For Instance, In July 2024, according to an article published in The Economic Times, the revised estimate of allocation to the Ministry of Health and Family Welfare showed an increase of approx. 1.73% over the revised estimate of 2022-23. This is done in the aim of developing high-value novel drugs, bio-pharmaceuticals and biosimilar that require considerable research and development efforts. The development of new biological products, such as monoclonal antibodies, vaccines, and gene therapies, requires the use of advanced cell culture media. These products require specific growth conditions, such as temperature, pH, and nutrient levels, which can be challenging to replicate in vitro. Advanced cell culture media that can support the growth and testing of these biological products is driving demand for specialized cell culture media.
Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE ASIA-PACIFIC CELL CULTURE MEDIA MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 MARKET APPLICATION COVERAGE GRID
2.8 PRODUCT LIFELINE CURVE
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTAL ANALYSIS
4.2 PORTERS FIVE FORCES ANALYSIS
5 ASIA-PACIFIC CELL CULTURE MEDIA MARKET: REGULATIONS
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 INCREASING FOCUS ON PERSONALIZED MEDICINE
6.1.2 ADVANCES IN CELL THERAPY AND REGENERATIVE MEDICINE
6.1.3 INCREASE IN R&D SPENDING ON BIOPHARMACEUTICAL PROJECTS
6.1.4 GROWING DEMAND FOR VACCINE DEVELOPMENT
6.2 RESTRAINTS
6.2.1 RISKS ASSOCIATED WITH CONTAMINATION
6.2.2 HIGH COST OF PRODUCTION
6.3 OPPORTUNITIES
6.3.1 RISING COLLABORATION AND PARTNERSHIPS
6.3.2 INCREASED DEMAND FOR BIOPHARMACEUTICALS AND VACCINES
6.3.3 INNOVATIONS IN 3D CELL CULTURE
6.4 CHALLENGES
6.4.1 COMPLEXITY OF MEDIA FORMULATION
6.4.2 INTENSE MARKET COMPETITION
7 ASIA-PACIFIC CELL CULTURE MEDIA MARKET, BY TYPE
7.1 OVERVIEW
7.2 CHEMICALLY DEFINED MEDIA
7.3 CLASSICAL MEDIA
7.4 SERUM-FREE MEDIA
7.4.1 CHO MEDIA
7.4.2 HEK 293 MEDIA
7.4.3 CAR T-CELL MEDIA
7.4.4 VERO CELL MEDIA
7.4.5 BHK MEDIA
7.4.6 INSECT CELL MEDIA
7.4.7 SERUM-FREE CELL MEDIA
7.4.8 OTHER SERUM-FREE MEDIA
7.5 SPECIALTY MEDIA
7.6 STEM CELL MEDIA
7.6.1 MESENCHYMAL STEM CELLS (MSCS)
7.6.2 NEURAL STEM CELLS (NSCS)
7.6.3 EMBRYONIC STEM CELLS (ESCS)
7.6.4 BONE MARROW
7.6.5 OTHERS
7.7 LYSOGENY BROTH (LB)
7.8 CUSTOM MEDIA FORMULATION
7.9 OTHERS
8 ASIA-PACIFIC CELL CULTURE MEDIA MARKET, BY APPLICATION
8.1 OVERVIEW
8.2 BIOPHARMACEUTICAL PRODUCTION
8.2.1 MONOCLONAL ANTIBODIES
8.2.2 VACCINES PRODUCTION
8.2.3 OTHERS
8.3 DRUG SCREENING & DEVELOPMENT
8.4 DIAGNOSTICS
8.5 REGENERATIVE MEDICINE & TISSUE ENGINEERING
8.5.1 STEM CELL AND GENE THERAPY
8.5.2 OTHERS
8.6 OTHERS
9 ASIA-PACIFIC CELL CULTURE MEDIA MARKET, BY END USER
9.1 OVERVIEW
9.2 BIOPHARMACEUTICAL COMPANIES
9.3 BIOTECHNOLOGY ORGANIZATIONS
9.4 ACADEMIC AND RESEARCH LABORATORIES
9.5 HOSPITALS
9.6 DIAGNOSTIC CENTERS
9.7 CELL BANKS
9.8 FORENSIC LABORATORIES
9.9 OTHERS
10 ASIA-PACIFIC CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL
10.1 OVERVIEW
10.2 DIRECT TENDERS
10.3 THIRD PARTY DISTRIBUTION
10.4 RETAILS SALES
11 ASIA-PACIFIC CELL CULTURE MEDIA MARKET, BY REGION
11.1 ASIA-PACIFIC
11.1.1 CHINA
11.1.2 JAPAN
11.1.3 INDIA
11.1.4 SOUTH KOREA
11.1.5 AUSTRALIA
11.1.6 SINGAPORE
11.1.7 THAILAND
11.1.8 MALAYSIA
11.1.9 INDONESIA
11.1.10 PHILIPPINES
11.1.11 REST OF ASIA-PACIFIC
12 ASIA-PACIFIC MULTIPLE HEREDITARY EXOSTOSIS MARKET: COMPANY LANDSCAPE
12.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
13 SWOT ANALYSIS
14 COMPANY PROFILES
14.1 THERMO FISHER SCIENTIFIC INC.
14.1.1 COMPANY SNAPSHOT
14.1.2 REVENUE ANALYSIS
14.1.3 COMPANY SHARE ANALYSIS
14.1.4 PRODUCT PORTFOLIO
14.1.5 RECENT DEVELOPMENT
14.2 MERCK KGAA
14.2.1 COMPANY SNAPSHOT
14.2.2 REVENUE ANALYSIS
14.2.3 COMPANY SHARE ANALYSIS
14.2.4 PRODUCT PORTFOLIO
14.2.5 RECENT DEVELOPMENTS
14.3 DANAHER CORPORATION (CYTIVA)
14.3.1 COMPANY SNAPSHOT
14.3.2 REVENUE ANALYSIS
14.3.3 COMPANY SHARE ANALYSIS
14.3.4 PRODUCT PORTFOLIO
14.3.5 RECENT DEVELOPMENTS
14.4 SARTORIUS AG
14.4.1 COMPANY SNAPSHOT
14.4.2 REVENUE ANALYSIS
14.4.3 COMPANY SHARE ANALYSIS
14.4.4 PRODUCT PORTFOLIO
14.4.5 RECENT DEVELOPMENTS
14.5 LONZA
14.5.1 COMPANY SNAPSHOT
14.5.2 REVENUE ANALYSIS
14.5.3 COMPANY SHARE ANALYSIS
14.5.4 PRODUCT PORTFOLIO
14.5.5 RECENT DEVELOPMENT
14.6 CORNING INCORPORATED
14.6.1 COMPANY SNAPSHOT
14.6.2 REVENUE ANALYSIS
14.6.3 COMPANY SHARE ANALYSIS
14.6.4 PRODUCT PORTFOLIO
14.6.5 RECENT UPDATES
14.7 AJINOMOTO CO., INC
14.7.1 COMPANY SNAPSHOT
14.7.2 REVENUE ANALYSIS
14.7.3 PRODUCT PORTFOLIO
14.7.4 RECENT DEVELOPMENT
14.8 AKRON BIOTECH
14.8.1 COMPANY SNAPSHOT
14.8.2 PRODUCT PORTFOLIO
14.8.3 RECENT DEVELOPMENTS
14.9 BD
14.9.1 COMPANY SNAPSHOT
14.9.2 REVENUE ANALYSIS
14.9.3 PRODUCT PORTFOLIO
14.9.4 RECENT UPDATES
14.1 BIO-RAD LABORATORIES, INC.
14.10.1 COMPANY SNAPSHOT
14.10.2 REVENUE ANALYSIS
14.10.3 PRODUCT PORTFOLIO
14.10.4 RECENT DEVELOPMENT
14.11 CAISSON LABS INC.
14.11.1 COMPANY SNAPSHOT
14.11.2 PRODUCT PORTFOLIO
14.11.3 RECENT UPDATES
14.12 CELL APPLICATION, INC.
14.12.1 COMPANY SNAPSHOT
14.12.2 PRODUCT PORTFOLIO
14.12.3 RECENT UPDATES
14.13 ELEX BIOLOGICAL PRODUCTS (SHANGHAI) CO., LTD.
14.13.1 COMPANY SNAPSHOT
14.13.2 PRODUCT PORTFOLIO
14.13.3 RECENT DEVELOPMENT
14.14 FUJIFILM HOLDINGS CORPORATION
14.14.1 COMPANY SNAPSHOT
14.14.2 REVENUE ANALYSIS
14.14.3 PRODUCT PORTFOLIO
14.14.4 RECENT UPDATES
14.15 HIMEDIA LABORATORIES
14.15.1 COMPANY SNAPSHOT
14.15.2 PRODUCT PORTFOLIO
14.15.3 RECENT UPDATES
14.16 KOH JIN-BIO CO., LTD.
14.16.1 COMPANY SNAPSHOT
14.16.2 PRODUCT PORTFOLIO
14.16.3 RECENT UPDATES
14.17 PAN-BIOTECH
14.17.1 COMPANY SNAPSHOT
14.17.2 PRODUCT PORTFOLIO
14.17.3 RECENT UPDATES
14.18 PROMOCELL GMBH
14.18.1 COMPANY SNAPSHOT
14.18.2 PRODUCT PORTFOLIO
14.18.3 RECENT UPDATES
14.19 SERA-SCANDIA A/S
14.19.1 COMPANY SNAPSHOT
14.19.2 PRODUCT PORTFOLIO
14.19.3 RECENT DEVELOPMENTS
14.2 STEMCELL TECHNOLOGIES
14.20.1 COMPANY SNAPSHOT
14.20.2 PRODUCT PORTFOLIO
14.20.3 RECENT DEVELOPMENT
14.21 TAKARA BIO INC.
14.21.1 COMPANY SNAPSHOT
14.21.2 REVENUE ANALYSIS
14.21.3 PRODUCT PORTFOLIO
14.21.4 RECENT DEVELOPMENTS
15 QUESTIONNAIRE
16 RELATED REPORTS
List of Table
TABLE 1 GMP REQUIREMENTS
TABLE 2 SCOPE OF THE CURRENT DOCUMENT
TABLE 3 ASIA-PACIFIC CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 4 ASIA-PACIFIC CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 5 ASIA-PACIFIC CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 6 ASIA-PACIFIC CHEMICALLY DEFINED MEDIA IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 7 ASIA-PACIFIC CLASSICAL MEDIA IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 8 ASIA-PACIFIC SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 9 ASIA-PACIFIC SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 10 ASIA-PACIFIC SPECIALTY MEDIA IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 11 ASIA-PACIFIC STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 12 ASIA-PACIFIC STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 13 ASIA-PACIFIC LYSOGENY BROTH (LB) IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 14 ASIA-PACIFIC CUSTOM MEDIA FORMULATION IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 15 ASIA-PACIFIC OTHERS IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 16 ASIA-PACIFIC CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 17 ASIA-PACIFIC BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 18 ASIA-PACIFIC BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 19 ASIA-PACIFIC DRUG SCREENING & DEVELOPMENT IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 20 ASIA-PACIFIC DIAGNOSTICS IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 21 ASIA-PACIFIC REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 22 ASIA-PACIFIC REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 23 ASIA-PACIFIC OTHERS IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 24 ASIA-PACIFIC CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 25 ASIA-PACIFIC BIOPHARMACEUTICAL COMPANIES IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 26 ASIA-PACIFIC BIOTECHNOLOGY ORGANIZATIONS IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 27 ASIA-PACIFIC ACADEMIC AND RESEARCH LABORATORIES IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 28 ASIA-PACIFIC HOSPITALS IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 29 ASIA-PACIFIC DIAGNOSTIC CENTERS IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 30 ASIA-PACIFIC CELL BANKS IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 31 ASIA-PACIFIC FORENSIC LABORATORIES IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 32 ASIA-PACIFIC OTHERS IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 33 ASIA-PACIFIC CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 34 ASIA-PACIFIC DIRECT TENDERS IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 35 ASIA-PACIFIC THIRD PARTY DISTRIBUTION IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 36 ASIA-PACIFIC RETAIL SALES IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 37 ASIA-PACIFIC CELL CULTURE MEDIA MARKET, BY COUNTRY, 2022-2031 (USD MILLION)
TABLE 38 ASIA-PACIFIC CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 39 ASIA-PACIFIC SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 40 ASIA-PACIFIC STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 41 ASIA-PACIFIC CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 42 ASIA-PACIFIC BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 43 ASIA-PACIFIC REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 44 ASIA-PACIFIC CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 45 ASIA-PACIFIC CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 46 CHINA CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 47 CHINA SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 48 CHINA STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 49 CHINA CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 50 CHINA BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 51 CHINA REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 52 CHINA CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 53 CHINA CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 54 JAPAN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 55 JAPAN SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 56 JAPAN STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 57 JAPAN CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 58 JAPAN BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 59 JAPAN REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 60 JAPAN CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 61 JAPAN CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 62 INDIA CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 63 INDIA SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 64 INDIA STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 65 INDIA CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 66 INDIA BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 67 INDIA REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 68 INDIA CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 69 INDIA CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 70 SOUTH KOREA CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 71 SOUTH KOREA SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 72 SOUTH KOREA STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 73 SOUTH KOREA CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 74 SOUTH KOREA BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 75 SOUTH KOREA REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 76 SOUTH KOREA CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 77 SOUTH KOREA CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 78 AUSTRALIA CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 79 AUSTRALIA SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 80 AUSTRALIA STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 81 AUSTRALIA CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 82 AUSTRALIA BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 83 AUSTRALIA REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 84 AUSTRALIA CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 85 AUSTRALIA CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 86 SINGAPORE CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 87 SINGAPORE SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 88 SINGAPORE STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 89 SINGAPORE CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 90 SINGAPORE BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 91 SINGAPORE REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 92 SINGAPORE CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 93 SINGAPORE CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 94 THAILAND CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 95 THAILAND SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 96 THAILAND STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 97 THAILAND CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 98 THAILAND BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 99 THAILAND REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 100 THAILAND CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 101 THAILAND CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 102 MALAYSIA CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 103 MALAYSIA SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 104 MALAYSIA STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 105 MALAYSIA CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 106 MALAYSIA BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 107 MALAYSIA REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 108 MALAYSIA CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 109 MALAYSIA CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 110 INDONESIA CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 111 INDONESIA SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 112 INDONESIA STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 113 INDONESIA CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 114 INDONESIA BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 115 INDONESIA REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 116 INDONESIA CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 117 INDONESIA CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 118 PHILIPPINES CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 119 PHILIPPINES SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 120 PHILIPPINES STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 121 PHILIPPINES CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 122 PHILIPPINES BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 123 PHILIPPINES REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 124 PHILIPPINES CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 125 PHILIPPINES CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 126 REST OF ASIA-PACIFIC CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
List of Figure
FIGURE 1 ASIA-PACIFIC CELL CULTURE MEDIA MARKET: SEGMENTATION
FIGURE 2 ASIA-PACIFIC CELL CULTURE MEDIA MARKET: DATA TRIANGULATION
FIGURE 3 ASIA-PACIFIC CELL CULTURE MEDIA MARKET: DROC ANALYSIS
FIGURE 4 ASIA-PACIFIC CELL CULTURE MEDIA MARKET: ASIA-PACIFIC VS REGIONAL MARKET ANALYSIS
FIGURE 5 ASIA-PACIFIC CELL CULTURE MEDIA MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 ASIA-PACIFIC CELL CULTURE MEDIA MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 ASIA-PACIFIC CELL CULTURE MEDIA MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 8 ASIA-PACIFIC CELL CULTURE MEDIA MARKET: DBMR MARKET POSITION GRID
FIGURE 9 ASIA-PACIFIC CELL CULTURE MEDIA MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 ASIA-PACIFIC CELL CULTURE MEDIA MARKET: SEGMENTATION
FIGURE 11 EXECUTIVE SUMMARY
FIGURE 12 STRATEGIC DECISIONS
FIGURE 13 INCREASING FOCUS ON PERSONALIZED MEDICINE IS DRIVING THE GROWTH OF THE ASIA-PACIFIC CELL CULTURE MEDIA MARKET FROM 2024 TO 2031
FIGURE 14 THE CHEMICALLY DEFINED MEDIA SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA-PACIFIC CELL CULTURE MEDIA MARKET IN 2024 AND 2031
FIGURE 15 DROC ANALYSIS
FIGURE 16 ASIA-PACIFIC CELL CULTURE MEDIA MARKET: BY TYPE, 2023
FIGURE 17 ASIA-PACIFIC CELL CULTURE MEDIA MARKET: BY TYPE, 2024-2031 (USD MILLION)
FIGURE 18 ASIA-PACIFIC CELL CULTURE MEDIA MARKET: BY TYPE, CAGR (2024-2031)
FIGURE 19 ASIA-PACIFIC CELL CULTURE MEDIA MARKET: BY TYPE, LIFELINE CURVE
FIGURE 20 ASIA-PACIFIC CELL CULTURE MEDIA MARKET: BY APPLICATION, 2023
FIGURE 21 ASIA-PACIFIC CELL CULTURE MEDIA MARKET: BY APPLICATION, 2024-2031 (USD MILLION)
FIGURE 22 ASIA-PACIFIC CELL CULTURE MEDIA MARKET: BY APPLICATION, CAGR (2024-2031)
FIGURE 23 ASIA-PACIFIC CELL CULTURE MEDIA MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 24 ASIA-PACIFIC CELL CULTURE MEDIA MARKET: BY END USER, 2023
FIGURE 25 ASIA-PACIFIC CELL CULTURE MEDIA MARKET: BY END USER, 2024-2031 (USD MILLION)
FIGURE 26 ASIA-PACIFIC CELL CULTURE MEDIA MARKET: BY END USER, CAGR (2024-2031)
FIGURE 27 ASIA-PACIFIC CELL CULTURE MEDIA MARKET: BY END USER, LIFELINE CURVE
FIGURE 28 ASIA-PACIFIC CELL CULTURE MEDIA MARKET: BY DISTRIBUTION CHANNEL, 2023
FIGURE 29 ASIA-PACIFIC CELL CULTURE MEDIA MARKET: BY DISTRIBUTION CHANNEL, 2024-2031 (USD MILLION)
FIGURE 30 ASIA-PACIFIC CELL CULTURE MEDIA MARKET: BY DISTRIBUTION CHANNEL, CAGR (2024-2031)
FIGURE 31 ASIA-PACIFIC CELL CULTURE MEDIA MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 32 ASIA-PACIFIC CELL CULTURE MEDIA MARKET: SNAPSHOT
FIGURE 33 ASIA-PACIFIC CELL CULTURE MEDIA MARKET: COMPANY SHARE 2023 (%)
